Study of the effects of AMG(alpha1-micoroglobulin) reduction rates on the survival, complications and prognosis in dialysis patients
Not Applicable
- Conditions
- Chronic hemodialysis in out-patients
- Registration Number
- JPRN-UMIN000038457
- Lead Sponsor
- Osaka City University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 4000
Inclusion Criteria
Not provided
Exclusion Criteria
Patients with malignancy, clinically overt infection, acute or severe illness, dementia and dialysis re-initiation after functional loss of transplanted kidney.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Survival and cardiovasculardisease events
- Secondary Outcome Measures
Name Time Method Survival or cardiovascular disease events